Study ID: TV48125-CNS-30056 | 2016-003278-42
Study Title
- A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Teva Identifier
- TV48125-CNS-30056 | 2016-003278-42
ClinicalTrials.gov Identifier
- NCT02945046
Study Status
- Terminated
Trial Condition(s)
- Episodic Cluster Headache
Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- January 19, 2017 - May 13, 2019
Phase
- Phase 3
Additional info
Study Type
Interventional
